POSTMENOPAUSAL WOMEN
Clinical trials for POSTMENOPAUSAL WOMEN explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL WOMEN trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL WOMEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can acupuncture with electricity melt belly fat and heal fatty liver?
Disease control Not yet recruitingThis study will test if electroacupuncture (acupuncture with mild electric pulses) can help postmenopausal women lose belly fat and improve fatty liver. Sixty women aged 50-60 with obesity and high liver enzymes will receive 12 weeks of treatment. Researchers will measure changes…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
AI breathing coach may soothe menopause pain without drugs
Symptom relief Not yet recruitingThis study tests whether relaxation and breathing exercises, guided by an AI system or a physiotherapist, can reduce pain and improve quality of life in postmenopausal women with long-lasting muscle and joint pain. About 48 women aged 45–65 will take part in an 8-week program wit…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Simple exercises and cream may help women stop leaking urine
Symptom relief Not yet recruitingThis study looks at whether combining pelvic floor muscle training with vaginal estrogen cream works better than estrogen cream alone for treating stress urinary incontinence (leaking urine when coughing, sneezing, or exercising) in postmenopausal women. About 115 women will be r…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New drug BL0175 tested for safety in postmenopausal women
Knowledge-focused Not yet recruitingThis early-stage study tests a single dose of a new drug called BL0175 in 27 postmenopausal women to see if it is safe and how long it stays in the body. It compares BL0175 to an existing drug, fulvestrant. The main goal is to check for side effects and measure drug levels in the…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: PHASE1 • Sponsor: Shanghai Best-Link Bioscience, LLC • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC